Note: Ligand Pharmaceuticals's revenues are gauged from an analysis of company filings.
Ligand Pharmaceuticals's Income Statement (based on Industry Averages)
Ligand Pharmaceuticals P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Trademark Applications
Trademark applications show the products and services that Ligand Pharmaceuticals is developing and marketing.
Ligand Pharmaceuticals doesn't have any recent trademark applications, indicating Ligand Pharmaceuticals is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
BEPRO Pharmaceutical research and development of a process to deliver pharmaceutical preparations
03/18/2021
VDP VERNALIS DESIGN PLATFORM drug discovery services
03/11/2019
VDP drug discovery services
03/11/2019
See all trademarks and details in the Full Report.
Market Share of Ligand Pharmaceuticals's Largest Competitors
A competitive analysis shows these companies are in the same general field as Ligand Pharmaceuticals, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Ligand Pharmaceuticals.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Ligand Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.